Evoke Pharma Announces 1-For-12 Reverse Stock Split Effective August 1, 2024
Portfolio Pulse from Benzinga Newsdesk
Evoke Pharma has announced a 1-for-12 reverse stock split effective August 1, 2024. The common stock will trade on a split-adjusted basis under the symbol EVOK with a new CUSIP 30049G302.

July 30, 2024 | 12:31 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Evoke Pharma is implementing a 1-for-12 reverse stock split effective August 1, 2024. The stock will trade on a split-adjusted basis under the symbol EVOK with a new CUSIP 30049G302.
Reverse stock splits are often implemented to increase the per-share price of a stock, which can help meet listing requirements or make the stock more attractive to investors. However, it does not change the company's market capitalization. The neutral score reflects the mixed potential impact on investor perception.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100